https://thelifesciencefeed.com/articles/ra-care-navigating-treatment-choices-eular-2026 The Life Science Feed en 2026-06-02 RA Care: Navigating Treatment Choices at EULAR 2026 https://thelifesciencefeed.com/articles/multidisciplinary-care-improves-spondyloarthritis-outcomes The Life Science Feed en 2026-06-02 Multidisciplinary Care Improves Spondyloarthritis Outcomes https://thelifesciencefeed.com/articles/immuno-fibrotic-crosstalk-rheumatology-eular-2026 The Life Science Feed en 2026-06-02 Immuno-Fibrotic Crosstalk: A New Target in Rheumatology https://thelifesciencefeed.com/articles/treat-to-target-sle-burden-benefit-risk-eular-2026 The Life Science Feed en 2026-06-02 Treat-to-Target in SLE: Balancing Burden, Benefit, and Risk https://thelifesciencefeed.com/articles/early-sle-disease-control-targeting-ifn-pathway-eular-2026 The Life Science Feed en 2026-06-02 Early SLE Disease Control: Targeting IFN Pathway at EULAR 2026 https://thelifesciencefeed.com/articles/eular-2026-psoriatic-disease-spectrum-highlights The Life Science Feed en 2026-06-02 EULAR 2026: Psoriatic Disease Spectrum Highlights https://thelifesciencefeed.com/articles/early-ild-recognition-sard-ssc-drivers-progression-workflow-solutions The Life Science Feed en 2026-06-02 Early ILD Recognition in SARD/SSc: Drivers of Progression and Workflow Solutions https://thelifesciencefeed.com/articles/eular-2026-earlier-axspa-recognition-improves-disease-burden The Life Science Feed en 2026-06-02 EULAR 2026: Earlier AxSpA Recognition Improves Disease Burden https://thelifesciencefeed.com/articles/early-intervention-inflammatory-joint-disease-osteoporosis The Life Science Feed en 2026-06-02 Early Intervention Crucial for Inflammatory Joint Disease, Osteoporosis https://thelifesciencefeed.com/articles/car-t-therapy-versus-bispecific-antibodies The Life Science Feed en 2026-06-01 CAR-T Therapy Versus Bispecific Antibodies https://thelifesciencefeed.com/articles/is-it-safe-to-switch-biosimilars The Life Science Feed en 2026-06-01T18:41:54.945417+00:00 Is It Safe To Switch Biosimilars? https://thelifesciencefeed.com/articles/why-half-of-psoriasis-patients-quit The Life Science Feed en 2026-05-28 Why Half Of Psoriasis Patients Quit https://thelifesciencefeed.com/articles/psoriasis-monitoring-landscape-guide The Life Science Feed en 2026-06-01T18:41:54.381875+00:00 Psoriasis Monitoring Landscape Guide https://thelifesciencefeed.com/articles/replacing-biologic-injections-with-oral-pills The Life Science Feed en 2026-06-01T18:41:54.203748+00:00 Replacing Biologic Injections With Oral Pills https://thelifesciencefeed.com/articles/the-glp-1-muscle-loss-dilemma The Life Science Feed en 2026-05-28 The GLP-1 Muscle Loss Dilemma https://thelifesciencefeed.com/articles/the-velvet-rope-of-weight-loss-drugs The Life Science Feed en 2026-05-28 The Velvet Rope Of Weight Loss Drugs https://thelifesciencefeed.com/articles/glp-1-drugs-protect-hearts-and-kidneys The Life Science Feed en 2026-05-28 GLP-1 Drugs Protect Hearts And Kidneys https://thelifesciencefeed.com/articles/rewiring-the-brain-to-silence-food-noise The Life Science Feed en 2026-05-28 Rewiring The Brain To Silence Food Noise https://thelifesciencefeed.com/articles/outsmarting-shape-shifting-lung-cancer-resistance The Life Science Feed en 2026-05-30 Outsmarting Shape-Shifting Lung Cancer Resistance https://thelifesciencefeed.com/articles/targeted-adcs-for-advanced-lung-cancer The Life Science Feed en 2026-05-29 Targeted ADCs For Advanced Lung Cancer https://thelifesciencefeed.com/articles/how-immunotherapy-unmasks-invisible-lung-cancer The Life Science Feed en 2026-05-29 How Immunotherapy Unmasks Invisible Lung Cancer https://thelifesciencefeed.com/articles/hacking-the-lung-cancer-genetic-code The Life Science Feed en 2026-05-29 Hacking the Lung Cancer Genetic Code https://thelifesciencefeed.com/articles/small-molecules-vs-car-t-in-cll The Life Science Feed en 2026-06-01 Small Molecules VS CAR-T In CLL https://thelifesciencefeed.com/articles/moving-car-t-to-earlier-myeloma-lines The Life Science Feed en 2026-06-01 Moving CAR-T To Earlier Myeloma Lines https://thelifesciencefeed.com/articles/car-t-masterstroke-or-biological-chaos The Life Science Feed en 2026-06-01 CAR-T Masterstroke Or Biological Chaos? https://thelifesciencefeed.com/articles/why-cheaper-humira-alternatives-face-resistance The Life Science Feed en 2026-06-01 Why Cheaper Humira Alternatives Face Resistance https://thelifesciencefeed.com/articles/stopping-spinal-fusion-or-protecting-the-gut The Life Science Feed en 2026-06-01 Stopping Spinal Fusion Or Protecting The Gut? https://thelifesciencefeed.com/articles/chasing-absolute-zero-in-rheumatoid-arthritis The Life Science Feed en 2026-06-01 Chasing Absolute Zero In Rheumatoid Arthritis https://thelifesciencefeed.com/articles/the-oral-surveillance-jak-inhibitor-controversy The Life Science Feed en 2026-06-01 The ORAL Surveillance JAK Inhibitor Controversy https://thelifesciencefeed.com/articles/managing-acute-heart-failure-and-cardiogenic-shock The Life Science Feed en 2026-06-01 Managing Acute Heart Failure And Cardiogenic Shock https://thelifesciencefeed.com/articles/semaglutide-for-obese-heart-failure-patients The Life Science Feed en 2026-06-01 Semaglutide For Obese Heart Failure Patients https://thelifesciencefeed.com/articles/diabetes-drugs-for-stiff-heart-failure The Life Science Feed en 2026-06-01 Diabetes Drugs For Stiff Heart Failure https://thelifesciencefeed.com/articles/how-four-drugs-beat-heart-failure The Life Science Feed en 2026-06-01 How Four Drugs Beat Heart Failure https://thelifesciencefeed.com/articles/asco-2026-june-1st-program-highlights-novel-immunotherapy-data The Life Science Feed en 2026-06-01 ASCO 2026 June 1st Program Highlights: Novel Immunotherapy Data https://thelifesciencefeed.com/articles/asco-2026-may-29th-program-highlights-novel-oncology-therapies The Life Science Feed en 2026-06-01T09:25:27.578159+00:00 ASCO 2026 May 29th Program Highlights: Novel Oncology Therapies https://thelifesciencefeed.com/articles/asco-2026-may-30th-program-highlights-immunotherapy-advances-in-solid-tumors The Life Science Feed en 2026-06-01T09:25:26.542602+00:00 ASCO 2026 May 30th Program Highlights: Immunotherapy Advances in Solid Tumors https://thelifesciencefeed.com/articles/tafasitamab-r-chop-boosts-frontline-dlbcl-outcomes-at-asco-2026 The Life Science Feed en 2026-06-01T09:24:33.079936+00:00 Tafasitamab-R-CHOP Boosts Frontline DLBCL Outcomes at ASCO 2026 https://thelifesciencefeed.com/articles/federal-vaping-policy-shifts-clinicians-front-line-youth-prevention The Life Science Feed en 2026-06-01T09:24:31.511877+00:00 Federal Vaping Policy Shifts, Clinicians Front Line in Youth Prevention https://thelifesciencefeed.com/articles/traffic-pollution-linked-to-distinct-chronic-rhinosinusitis-phenotypes The Life Science Feed en 2026-06-01T09:24:29.914485+00:00 Traffic Pollution Linked to Distinct Chronic Rhinosinusitis Phenotypes https://thelifesciencefeed.com/articles/asco-2026-may-31st-program-highlights-focus-on-novel-immunotherapies The Life Science Feed en 2026-05-31 ASCO 2026 May 31st Program Highlights: Focus on Novel Immunotherapies https://thelifesciencefeed.com/articles/hyrnuo-sevabertinib-asco-2026 The Life Science Feed en 2026-06-01 HYRNUO® (Sevabertinib) Shows Efficacy in Advanced Solid Tumours https://thelifesciencefeed.com/articles/oncodetect-mrd-test-analytical-clinical-asco-2026 The Life Science Feed en 2026-06-01 Oncodetect® MRD Test Shows Analytical Validity, Clinical Utility at ASCO https://thelifesciencefeed.com/articles/tace-camrelizumab-rivoceranib-unresectable-hcc The Life Science Feed en 2026-06-01 TACE + Camrelizumab/Rivoceranib Improves OS in Unresectable HCC https://thelifesciencefeed.com/articles/fixed-duration-bcl2-combo-time-off-treatment-1l-cll The Life Science Feed en 2026-06-01 Fixed-Duration BCL-2 Combo Offers Time Off Treatment in 1L CLL https://thelifesciencefeed.com/articles/2l-combination-therapy-rrmm-pi-imid-asco-2026 The Life Science Feed en 2026-06-01 New 2L+ Combination Therapy Shows Efficacy in RRMM Post-PI/IMiD https://thelifesciencefeed.com/articles/subcutaneous-immunotherapy-alternative-administration-asco-2026 The Life Science Feed en 2026-06-01 Subcutaneous Immunotherapy Offers Alternative Administration at ASCO 2026 https://thelifesciencefeed.com/articles/reassuring-data-high-efficacy-ms-meds-pregnancy The Life Science Feed en 2026-05-31T20:59:50.217518+00:00 Reassuring Data for High-Efficacy MS Meds in Pregnancy https://thelifesciencefeed.com/articles/alcohol-and-sugar-a-dual-metabolic-challenge-for-patients The Life Science Feed en 2026-05-31T20:34:47.171457+00:00 Alcohol and Sugar: A Dual Metabolic Challenge for Patients